Regulatory Intelligence Graematter specializes in regulatory data analysis and actionable intelligence for the medical device sector, presenting an opportunity to upsell deeper regulatory monitoring services, tailored dashboards, and ongoing compliance guidance to accelerate strategic decision making.

SOFIE System With the SOFIE Regulatory Intelligence System as a core asset, there is potential to position Graematter as a platform partner for customers seeking automated regulatory updates, issue tracking, and proactive risk mitigation across product lifecycles.

Biotech Focus As a biotech research firm with regulatory navigation expertise and a small team, Graematter may benefit from scalable, low-friction solutions such as consulting retainers, modular analytics add‑ons, and subscription services to expand revenue without large hires.

Growth Appetite Current revenue and recent funding indicate a growing demand for regulatory intelligence; sales outreach can target mid‑sized medical device and biotech firms looking to streamline compliance and reduce time to market.

Tech Stack Fit Leveraging existing tech like AWS, Drupal, and analytics tools suggests opportunities for cross-sell of data integration, secure data workflows, and client portal enhancements that improve adoption and renewals.